World's Best Scientists 2026 revealed!
Sverre E. Kjeldsen

Sverre E. Kjeldsen

D-Index & Metrics

Medicine

D-Index
118
Citations
169184
World Ranking
3946
National Ranking
16

Overview

Sverre E. Kjeldsen is affiliated with the University of Oslo in Norway and specializes in medical research primarily within the field of cardiology and cardiovascular medicine. Their work encompasses a notable number of publications, focusing extensively on hypertension and related cardiovascular issues.

The main field of study covered by Kjeldsen includes:

  • Medicine

Within this domain, the subfields of particular emphasis are:

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Surgery
  • Public Health, Environmental and Occupational Health
  • Nutrition and Dietetics

The primary topics investigated in Kjeldsen's research include:

  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control
  • Hormonal Regulation and Hypertension
  • Cardiovascular Health and Disease Prevention
  • Sodium Intake and Health
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Syncope and Autonomic Disorders

Frequent co-authors in their academic work have included:

  • Giuseppe Mancia
  • Michel Burnier
  • Reinhold Kreutz
  • Krzysztof Narkiewicz
  • Stevo Julius

Kjeldsen's publications often appear in well-established journals such as:

  • Journal of Hypertension
  • Blood Pressure
  • Hypertension
  • European Journal of Internal Medicine
  • Tidsskrift for Den norske legeforening

Selected recent papers authored or co-authored by Kjeldsen cover key aspects of hypertension and cardiovascular risk and include:

  • 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension, 2023, Journal of Hypertension
  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis, 2021, The Lancet
  • Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk, 2020, Circulation
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis, 2021, The Lancet
  • Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension, 2021, Hypertension

Best Publications

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • 2007 Guidelines for the management of arterial hypertension

    Giuseppe Mancia;Guy De Backer;Anna Dominiczak;Renata Cifkova

  • 2018 ESC/ESH Guidelines for the management of arterial hypertension.

    Williams B;Mancia G;Spiering W;Agabiti Rosei E

  • 2007 Guidelines for the Management of Arterial Hypertension : The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Guy De Backer;Anna F. Dominiczak;Renata Cifkova

  • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Björn Dahlöf;Richard B Devereux;Sverre E Kjeldsen;Stevo Julius

  • European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

    J Perk;G De Backer;H Gohlke;I Graham

  • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

    Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel

  • Reappraisal of European guidelines on hypertension management:: A European Society of Hypertension Task Force document

    Giuseppe Mancia;Stéphane Laurent;Enrico Agabiti-Rosei;Ettore Ambrosioni

  • 2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension

    G Mancia;EA Rosei;R Cifkova;G DeBacker

  • Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

    Stevo Julius;Sverre E Kjeldsen;Michael Weber;Hans R Brunner

  • Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

    Björn Dahlöf;Peter S Sever;Neil R Poulter;Hans Wedel

  • 2018 ESC/ESH Guidelines for the management of arterial hypertension : The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

    Bryan Williams;Giuseppe Mancia;Wilko Spiering;Enrico Agabiti Rosei

  • 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.

    Giuseppe Mancia;Guy De Backer;Anna Dominiczak;Renata Cifkova

  • Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Lars H Lindholm;Hans Ibsen;Björn Dahlöf;Richard B Devereux

  • 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redán

  • Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

    Lennart Hansson;Thomas Hedner;Per Lund-Johansen;Sverre Erik Kjeldsen

  • Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study

    Kristian Wachtell;Mika Lehto;Eva Gerdts;Michael H. Olsen

  • Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.

    Michael A Weber;Stevo Julius;Sverre E Kjeldsen;Hans R Brunner

  • 2013 ESH/ESC Practice guidelines for the management of arterial hypertension

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

Frequent Co-Authors

Richard B. Devereux
Richard B. Devereux Cornell University
Björn Dahlöf
Björn Dahlöf Sahlgrenska University Hospital
Stevo Julius
Stevo Julius University of Michigan–Ann Arbor
Suzanne Oparil
Suzanne Oparil University of Alabama at Birmingham
Peter M. Okin
Peter M. Okin Cornell University
Giuseppe Mancia
Giuseppe Mancia University of Milano-Bicocca
Kristian Wachtell
Kristian Wachtell Cornell University
Markku S. Nieminen
Markku S. Nieminen University of Helsinki
Michel Burnier
Michel Burnier University of Lausanne
Alberto Zanchetti
Alberto Zanchetti University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in medicine, you might also explore related online healthcare degrees and career pathways. There is a wide range of flexible options that let you balance your studies with other commitments. For those interested in healthcare leadership, it's important to consider which online healthcare degree programs are recognized for their accreditation by cahme? Accreditation ensures your qualification meets high professional standards and is valued by employers.

Nurses looking to advance their credentials might consider an rn to bsn online with no clinicals program, which can save time and provide needed flexibility. If you are aiming for a doctoral degree, accelerated msn to dnp programs offer a fast-track to leadership roles, while those conscious of cost can find affordable dnp programs that don’t compromise on quality.

Exploring these related online degree programs can help open additional opportunities in healthcare, set the stage for advanced roles, and support lifelong learning in the medical field.

Best Scientists Citing Sverre E. Kjeldsen

Trending Scientists

Recently Published Articles